Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.
| Autor: | Thiant, S., Moutuou, M. M., Laflamme, P., Boumedine, R. Sidi, Leboeuf, D. M., Busque, L., Roy, J., Guimond, M. |
|---|---|
| Předmět: | |
| Zdroj: | Blood Cancer Journal; Nov2020, Vol. 10 Issue 11, p1-1, 1p |
| Abstrakt: | A correction to this paper has been published and can be accessed via a link at the top of the paper. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|